| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Jan―10 |
Angiotensin-converting enzyme 2 and hepatic SARS-CoV-2 infection: Regulation, association, and therapeutic implications |
Yu-Wei Luo, Ai-Long Huang, Kai-Fu Tang |
| 2 |
[GO] |
2024―Sep―26 |
Long COVID and gut candidiasis: What is the existing relationship? |
Filippo Bistagnino, Davide Pizzi, Filippo Mantovani, Jacopo Rosso Antonino, Marcos Roberto Tovani-Palone |
| 3 |
[GO] |
2024―Aug―13 |
Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19 |
Angus K Jacobs, Steven D Morley, Kay Samuel, Katie Morgan, Lyndsey Boswell, Timothy J Kendall, David A Dorward, Jonathan A Fallowfield, Peter C Hayes, John N Plevris |
| 4 |
[GO] |
2024―Jun―05 |
Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications |
Alfonso Rodriguez-Espada, Moises Salgado-de la Mora, Briana Mariette Rodriguez-Paniagua, Nathaly Limon-de la Rosa, Monica Itzel Martinez-Gutierrez, Santiago Pastrana-Brandes, Nalu Navarro-Alvarez |
| 5 |
[GO] |
2024―Mai―27 |
Excess non-COVID-19-related mortality among inflammatory bowel disease decedents during the COVID-19 pandemic |
Sarah Rotondo-Trivette, Xin-Yuan He, Jamil S Samaan, Fan Lv, Emily Truong, Michaela Juels, Anthony Nguyen, Xu Gao, Jian Zu, Yee Hui Yeo, Fan-Pu Ji, Gil Y Melmed |
| 6 |
[GO] |
2024―Mrz―21 |
Current remarks and future directions on the interactions between metabolic dysfunction-associated fatty liver disease and COVID-19 |
Leonidas Brilakis, Eirini Theofilogiannakou, Panagis M Lykoudis |
| 7 |
[GO] |
2023―Jul―13 |
Research landscape on COVID-19 and liver dysfunction: A bibliometric analysis |
Sa'ed H Zyoud |
| 8 |
[GO] |
2023―Jul―06 |
Mortality from chronic liver disease: Recent trends and impact of the COVID-19 pandemic |
Ugo Fedeli, Claudio Barbiellini Amidei, Veronica Casotto, Enrico Grande, Mario Saia, Alberto Zanetto, Francesco Paolo Russo |
| 9 |
[GO] |
2023―Jul―06 |
Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients |
Alfredo Papa, Marcello Covino, Sara Sofia De Lucia, Angelo Del Gaudio, Marcello Fiorani, Giorgia Polito, Carlo Romano Settanni, Andrea Piccioni, Francesco Franceschi, Antonio Gasbarrini |
| 10 |
[GO] |
2023―Mai―16 |
Gastrointestinal manifestations of long-term effects after COVID-19 infection in patients with dialysis or kidney transplantation: An observational cohort study |
Wiwat Chancharoenthana, Supitcha Kamolratanakul, Asada Leelahavanichkul, Wassawon Ariyanon, Sutatip Chinpraditsuk, Rattanaporn Saelim, Somratai Vadcharavivad, Weerapong Phumratanaprapin, Polrat Wilairatana |
| 11 |
[GO] |
2023―Apr―24 |
SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups |
George D Liatsos |
| 12 |
[GO] |
2023―Apr―14 |
Mechanisms of gastrointestinal barrier dysfunction in COVID-19 patients |
Weijie Xue, Masaki Honda, Taizo Hibi |
| 13 |
[GO] |
2023―Apr―12 |
COVID-19 related biliary injury: A review of recent literature |
Sujani Yadlapati, Simone A. Jarrett, Daniel Baik, Adib Chaaya |
| 14 |
[GO] |
2023―Apr―12 |
Insight into the liver dysfunction in COVID-19 patients: Molecular mechanisms and possible therapeutic strategies |
Naina Khullar, Jasvinder Singh Bhatti, Satwinder Singh, Bhawana Thukral, P Hemachandra Reddy, Gurjit Kaur Bhatti |
| 15 |
[GO] |
2023―Mrz―30 |
Interferon-lambda: New functions on intestinal symptoms in COVID-19 |
Yi-Yang Pan, Liu-Can Wang, Feng Yang, Min Yu |
| 16 |
[GO] |
2023―Mrz―27 |
Autoimmune liver diseases and SARS-CoV-2 |
Costantino Sgamato, Alba Rocco, Debora Compare, Stefano Minieri, Stefano Andrea Marchitto, Simone Maurea, Gerardo Nardone |
| 17 |
[GO] |
2023―Mrz―17 |
Modulation of gut microbiota as a potential therapy to manipulate drug-induced hepatic damage in COVID-19 patients |
Khansa Ahsan, Munir Ahmad Anwar, Nayla Munawar |
| 18 |
[GO] |
2023―Feb―20 |
COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes |
Zeinab Nabil Ahmed Said, Safinaz Adel El Habashy, Samy Zaky |
| 19 |
[GO] |
2023―Feb―10 |
COVID-19 and liver injury in individuals with obesity |
Ioannis G Lempesis, Eleni Karlafti, Petros Papalexis, George Fotakopoulos, Kyriakos Tarantinos, Vasileios Lekakis, Stavros P Papadakos, Evangelos Cholongitas, Vasiliki E Georgakopoulou |
| 20 |
[GO] |
2023―Feb―10 |
Relation of COVID-19 with liver diseases and their impact on healthcare systems: The Portuguese case |
Sara Fernandes, Milaydis Sosa-Napolskij, Graça Lobo, Isabel Silva |
| 21 |
[GO] |
2023―Feb―02 |
Outcomes of COVID-19 among patients with liver disease |
Isidora Vujčić |
| 22 |
[GO] |
2023―Feb―02 |
Liver involvement in patients with COVID-19 infection: A comprehensive overview of diagnostic imaging features |
Davide Ippolito, Cesare Maino, Federica Vernuccio, Roberto Cannella, Riccardo Inchingolo, Michele Dezio, Riccardo Faletti, Pietro Andrea Bonaffini, Marco Gatti, Sandro Sironi |
| 23 |
[GO] |
2023―Feb―02 |
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination |
Riccardo Nevola, Livio Criscuolo, Domenico Beccia, Augusto Delle Femine, Rachele Ruocco, Simona Imbriani, Maria Alfano, Angela Villani, Antonio Russo, Pasquale Perillo, Raffaele Marfella, Luigi Elio Adinolfi, Ferdinando Carlo Sasso, Aldo Marrone, Luca Rinaldi |
| 24 |
[GO] |
2023―Jan―20 |
COVID-19 and the liver: Are footprints still there? |
Tarana Gupta, Hemant Sharma |
| 25 |
[GO] |
2023―Jan―20 |
Trends in gastrointestinal disease hospitalizations and outcomes during the first year of the coronavirus pandemic |
Ayooluwatomiwa Deborah Adekunle, Muni Rubens, Mary Sedarous, Tahniyat Tariq, Philip N Okafor |
| 26 |
[GO] |
2023―Jan―12 |
COVID-19 and hepatic injury: Diversity and risk assessment |
Fares E M Ali, Mostafa K Abd El-Aziz, Mahmoud M Ali, Osama M Ghogar, Adel G Bakr |
| 27 |
[GO] |
2023―Jan―12 |
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease |
Mohammad Sadiq Jeeyavudeen, Rahul Chaudhari, Joseph M Pappachan, Sherouk Fouda |
| 28 |
[GO] |
2023―Jan―12 |
Potential role of the microbiome in liver injury during COVID-19: Further research is needed |
Marcos Roberto Tovani-Palone, Paolo Pedersini |
| 29 |
[GO] |
2023―Jan―05 |
COVID-19 and liver injury: An ongoing challenge |
Ioanna Papagiouvanni, Serafeim-Chrysovalantis Kotoulas, Athanasia Pataka, Dionisios G Spyratos, Konstantinos Porpodis, Afroditi K Boutou, Georgios Papagiouvannis, Ioanna Grigoriou, Christos Vettas, Ioannis Goulis |
| 30 |
[GO] |
2023―Jan―05 |
Liver injury in COVID-19: Clinical features, potential mechanisms, risk factors and clinical treatments |
Shu-Wu Zhao, Yi-Ming Li, Yi-Lin Li, Chen Su |
| 31 |
[GO] |
2023―Jan―05 |
Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier? |
Christoph G Dietrich, Andreas Geier, Uta Merle |
| 32 |
[GO] |
2023―Jan―03 |
Liver pathology in COVID-19 related death and leading role of autopsy in the pandemic |
Martina Zanon, Margherita Neri, Stefano Pizzolitto, Davide Radaelli, Monica Concato, Michela Peruch, Stefano D'Errico |
| 33 |
[GO] |
2022―Dez―26 |
Mechanism and potential treatments for gastrointestinal dysfunction in patients with COVID-19 |
Yang Yao, Zhu-Jun Liu, Yu-Kun Zhang, Hui-Jun Sun |
| 34 |
[GO] |
2022―Dez―26 |
COVID-19 vaccination and liver disease |
Sotaro Ozaka, Takashi Kobayashi, Kazuhiro Mizukami, Kazunari Murakami |
| 35 |
[GO] |
2022―Dez―26 |
Molecular mechanisms implicated in SARS-CoV-2 liver tropism |
Jorge Quarleri, M. Victoria Delpino |
| 36 |
[GO] |
2022―Dez―19 |
Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative review |
Effie Polyzogopoulou, Pinelopi Amoiridou, Theodore P Abraham, Ioannis Ventoulis |
| 37 |
[GO] |
2022―Dez―19 |
Liver injury in COVID-19: A minireview |
Wen-Shu Hu, Fang-Ying Jiang, Wen Shu, Rong Zhao, Ji-Min Cao, De-Ping Wang |
| 38 |
[GO] |
2022―Dez―19 |
Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential |
Hui Xiang, Qi-Ping Liu |
| 39 |
[GO] |
2022―Dez―06 |
Correlation between COVID-19 and hepatitis B: A systematic review |
Yan-Fei He, Zhi-Gang Jiang, Ni Wu, Ning Bian, Jun-Lin Ren |
| 40 |
[GO] |
2022―Dez―01 |
COVID-19 drug-induced liver injury: A recent update of the literature |
Lekha Saha, Soumya Vij, Kajal Rawat |
| 41 |
[GO] |
2022―Dez―01 |
Gastrointestinal microbiota: A predictor of COVID-19 severity? |
Maria Adriana Neag, Damiana-Maria Vulturar, Diana Gherman, Codrin-Constantin Burlacu, Doina Adina Todea, Anca Dana Buzoianu |
| 42 |
[GO] |
2022―Nov―24 |
Virological and histological evaluation of intestinal samples in COVID-19 patients |
Dajana Cuicchi, Liliana Gabrielli, Maria Lucia Tardio, Giada Rossini, Antonietta D’Errico, Pierluigi Viale, Tiziana Lazzarotto, Gilberto Poggioli |
| 43 |
[GO] |
2022―Nov―09 |
COVID-19 associated liver injury: A general review with special consideration of pregnancy and obstetric outcomes |
Katherine M. Cooper, Alessandro Colletta, Alison M. Asirwatham, Tiffany A. Moore Simas, Deepika Devuni |
| 44 |
[GO] |
2022―Okt―28 |
Interaction between gut microbiota and COVID-19 and its vaccines |
John S M Leung |
| 45 |
[GO] |
2022―Okt―18 |
COVID-19 and hepatorenal syndrome |
Henry H L Wu, Varinder S Athwal, Philip A Kalra, Rajkumar Chinnadurai |
| 46 |
[GO] |
2022―Okt―18 |
Effects of COVID-19 on the liver: The experience of a single center |
Valentina Liakina, Ieva Stundiene, Gabriele Milaknyte, Ramune Bytautiene, Rosita Reivytyte, Roma Puronaite, Gintare Urbanoviciute, Edita Kazenaite |
| 47 |
[GO] |
2022―Okt―18 |
SARS-CoV-2-induced liver injury: A review article on the high-risk populations, manifestations, mechanisms, pathological changes, management, and outcomes |
Alvin Oliver Payus, Malehah Mohd Noh, Nornazirah Azizan, Raman Muthukaruppan Chettiar |
| 48 |
[GO] |
2022―Sep―29 |
Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19 |
Ricardo Ulises Macías-Rodríguez, Alberto Adrián Solís-Ortega, Victoria J Ornelas-Arroyo, Astrid Ruiz-Margáin, Maria Sarai González-Huezo, Nestor A Urdiales-Morán, Berenice M Román-Calleja, Juan M Mayorquín-Aguilar, José A González-Regueiro, Alejandro Campos-Murguía, Israel Vicente Toledo-Coronado, Mónica Chapa-Ibargüengoitia, Bernardo Valencia-Peña, Carlos Fernando Martínez-Cabrera, Nayelli C Flores-García |
| 49 |
[GO] |
2022―Sep―23 |
SARS-CoV-2 and the pancreas: What do we know about acute pancreatitis in COVID-19 positive patients? |
Giuseppe Brisinda, Maria Michela Chiarello, Giuseppe Tropeano, Gaia Altieri, Caterina Puccioni, Pietro Fransvea, Valentina Bianchi |
| 50 |
[GO] |
2022―Jul―01 |
Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity |
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Kuldeep Dhama, Sang-Soo Lee |
| 51 |
[GO] |
2022―Mai―17 |
Review on acute pancreatitis attributed to COVID-19 infection |
Takumi Onoyama, Hiroki Koda, Wataru Hamamoto, Shiho Kawahara, Yuri Sakamoto, Taro Yamashita, Hiroki Kurumi, Soichiro Kawata, Yohei Takeda, Kazuya Matsumoto, Hajime Isomoto |
| 52 |
[GO] |
2022―Apr―24 |
Aspartate transferase-to-platelet ratio index-plus: A new simplified model for predicting the risk of mortality among patients with COVID-19 |
Ali Madian, Ahmed Eliwa, Hytham Abdalla, Haitham A Azeem Aly |
| 53 |
[GO] |
2022―Apr―14 |
COVID-19 and liver dysfunction: What nutritionists need to know |
Ming-Ke Wang, Xue-Lu Yu, Li-Yun Zhou, Hong-Mei Si, Ju-Fen Hui, Deng-Yong Hou, Wei-Peng Li, Ji-Shun Yang |
| 54 |
[GO] |
2022―Mrz―16 |
Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship |
Damiano D’Ardes, Andrea Boccatonda, Giulio Cocco, Stefano Fabiani, Ilaria Rossi, Marco Bucci, Maria Teresa Guagnano, Cosima Schiavone, Francesco Cipollone |
| 55 |
[GO] |
2022―Feb―07 |
COVID-19, liver dysfunction and pathophysiology: A conceptual discussion |
Jucier Gonçalves Júnior |
| 56 |
[GO] |
2022―Jan―24 |
Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients |
Arunkumar Krishnan, Laura Prichett, Xueting Tao, Saleh A Alqahtani, James P Hamilton, Esteban Mezey, Alexandra T Strauss, Ahyoung Kim, James J Potter, Po-Hung Chen, Tinsay A Woreta |
| 57 |
[GO] |
2022―Jan―13 |
Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs |
Andrzej S Tarnawski, Amrita Ahluwalia |
| 58 |
[GO] |
2021―Dez―23 |
Strategy for the control of drug-induced liver injury due to investigational treatments/drugs for COVID-19 |
Ken Sato, Yuichi Yamazaki, Toshio Uraoka |
| 59 |
[GO] |
2021―Dez―09 |
COVID-19 and gut immunomodulation |
Koushik Roy, Sidra Agarwal, Rajib Banerjee, Manash K Paul, Prabhat K Purbey |
| 60 |
[GO] |
2021―Dez―09 |
Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar |
Muhammad Umair Khan, Kamran Mushtaq, Deema Hussam Alsoub, Phool Iqbal, Fateen Ata, Hammad Shabir Chaudhry, Fatima Iqbal, Girisha Balaraju, Muna A Al Maslamani, Betsy Varughese, Rajvir Singh, Khalid Al Ejji, Saad Al Kaabi, Yasser Medhat Kamel, Adeel Ajwad Butt |
| 61 |
[GO] |
2021―Dez―09 |
COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations |
Abhishek Bhurwal, Carlos D Minacapelli, Evan Orosz, Kapil Gupta, Christopher Tait, Ishita Dalal, Clark Zhang, Eric Zhao, Vinod K Rustgi |
| 62 |
[GO] |
2021―Dez―09 |
Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment |
Naser-Aldin Lashgari, Nazanin Momeni Roudsari, Saeideh Momtaz, Amir Hossein Abdolghaffari |
| 63 |
[GO] |
2021―Dez―01 |
SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted |
Henu Kumar Verma, LVKS Bhaskar |
| 64 |
[GO] |
2021―Nov―25 |
COVID-19: Effect on gastroenterology and hepatology service provision and training: Lessons learnt and planning for the future |
Muhammad Raheel Anjum, Jodie Chalmers, Rizwana Hamid, Neil Rajoriya |
| 65 |
[GO] |
2021―Nov―25 |
SARS-CoV-2 infection in liver transplant recipients: A complex relationship |
Ricardo Wesley Alberca, Gil Benard, Gabriela Gama Freire Alberca, Maria Notomi Sato |
| 66 |
[GO] |
2021―Nov―19 |
COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms |
Carlo Romano Settanni, Gianluca Ianiro, Francesca Romana Ponziani, Stefano Bibbò, Jonathan Philip Segal, Giovanni Cammarota, Antonio Gasbarrini |
| 67 |
[GO] |
2021―Nov―10 |
Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease |
David Bernstein, Nitzan Roth, Angela Kim, Marica Epstein, David Hirschwerk, Charlotte L Kvasnovsky, Sanjaya K Satapathy |
| 68 |
[GO] |
2021―Nov―10 |
Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study |
Shimaa Afify, Basem Eysa, Fatma Abdel Hamid, Omnia M Abo-Elazm, Mohamed A Edris, Rabab Maher, Ahmed Abdelhalim, Muhammad Mostafa Abdel Ghaffar, Dalia A Omran, Hend Ibrahim Shousha |
| 69 |
[GO] |
2021―Nov―10 |
Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic |
Caterina Sagnelli, Mariantonietta Pisaturo, Caterina Curatolo, Alessio Vinicio Codella, Nicola Coppola, Evangelista Sagnelli |
| 70 |
[GO] |
2021―Nov―05 |
Gut microbiota in a population highly affected by obesity and type 2 diabetes and susceptibility to COVID-19 |
Jaime García-Mena, Karina Corona-Cervantes, Daniel Cuervo-Zanatta, Tizziani Benitez-Guerrero, Juan Manuel Vélez-Ixta, Norma Gabriela Zavala-Torres, Loan Edel Villalobos-Flores, Fernando Hernández-Quiroz, Claudia Perez-Cruz, Selvasankar Murugesan, Fernando Guadalupe Bastida-González, Paola Berenice Zárate-Segura |
| 71 |
[GO] |
2021―Okt―27 |
Gastrointestinal and hepatic involvement during COVID-19 pandemic: A focus on pediatric population and possible future implications |
Rossella Sica, Serena Pennoni, Laura Penta, Sara Riccioni, Giuseppe Di Cara, Alberto Verrotti |
| 72 |
[GO] |
2021―Okt―27 |
Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study |
Hend Ibrahim Shousha, Shimaa Afify, Rabab Maher, Noha Asem, Eman Fouad, Ehab F Mostafa, Mohammed A Medhat, Amr Abdalazeem, Hazem Elmorsy, Miriam M Aziz, Rateba S Mohammed, Mohamed Ibrahem, Hassan Elgarem, Dalia Omran, Mohamed Hassany, Bassem Elsayed, Ahmed Y Abdelaziz, Mohamed El Kassas |
| 73 |
[GO] |
2021―Okt―19 |
Impact of COVID-19 pandemic on the neuropsychiatric status of Wilson’s disease |
Giuseppe Lanza, Massimiliano Godani, Raffaele Ferri, Alberto Raggi |
| 74 |
[GO] |
2021―Okt―19 |
Cathepsin L, transmembrane peptidase/serine subfamily member 2/4, and other host proteases in COVID-19 pathogenesis - with impact on gastrointestinal tract |
Izabela Berdowska, Malgorzata Matusiewicz |
| 75 |
[GO] |
2021―Okt―19 |
Evaluation of botanicals as potential COVID-19 symptoms terminator |
Ufuk Koca Caliskan, Methiye Mancak Karakus |
| 76 |
[GO] |
2021―Sep―29 |
Gastrointestinal symptoms in patients with COVID-19: Is there a relationship with mortality and new variations of SARS-CoV-2? |
Igor Braga Ribeiro, Diogo Turiani Hourneaux de Moura, Eduardo Guimarães Hourneaux de Moura |
| 77 |
[GO] |
2021―Sep―23 |
Liver disease in the era of COVID-19: Is the worst yet to come? |
Ivana Mikolasevic, Dorotea Bozic, Tajana Pavić, Alen Ruzic, Goran Hauser, Marija Radic, Delfa Radic-Kristo, Melanija Razov-Radas, Zeljko Puljiz, Sandra Milic |
| 78 |
[GO] |
2021―Sep―14 |
Liver-spleen axis dysfunction in COVID-19 |
Sara Cococcia, Marco Vincenzo Lenti, Giovanni Santacroce, Giovanna Achilli, Federica Borrelli de Andreis, Antonio Di Sabatino |
| 79 |
[GO] |
2021―Sep―14 |
Environmental perspectives of COVID-19 outbreaks: A review |
Palas Samanta, Apurba Ratan Ghosh |
| 80 |
[GO] |
2021―Sep―09 |
Liver disorders in COVID-19, nutritional approaches and the use of phytochemicals |
Nancy Vargas-Mendoza, Jazmín García-Machorro, Marcelo Angeles-Valencia, Marlet Martínez-Archundia, Eduardo Osiris Madrigal-Santillán, Ángel Morales-González, Liliana Anguiano-Robledo, José A Morales-González |
| 81 |
[GO] |
2021―Sep―09 |
Liver disease and COVID-19: The link with oxidative stress, antioxidants and nutrition |
Danijela Ristic-Medic, Snjezana Petrovic, Aleksandra Arsic, Vesna Vucic |
| 82 |
[GO] |
2021―Sep―01 |
Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19 |
Alejandro Campos-Murguía, Berenice M Román-Calleja, José A González-Regueiro, Ivonne Hurtado-Díaz-de-León, Alberto Adrián Solís-Ortega, Nayelli C Flores-García, Ignacio García-Juárez, Astrid Ruiz-Margáin, Ricardo Ulises Macías-Rodríguez |
| 83 |
[GO] |
2021―Sep―01 |
Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future |
Chiara Viganò, Giacomo Mulinacci, Andrea Palermo, Donatella Barisani, Lorena Pirola, Maria Fichera, Pietro Invernizzi, Sara Massironi |
| 84 |
[GO] |
2021―Aug―24 |
Intestinal ischemic manifestations of SARS-CoV-2: Results from the ABDOCOVID multicentre study |
Lorenzo Norsa, Pietro Andrea Bonaffini, Maja Caldato, Cristiana Bonifacio, Aurelio Sonzogni, Amedeo Indriolo, Clarissa Valle, Federica Furfaro, Alice Bonanomi, Paolo Niccolò Franco, Mauro Gori, Veronica Smania, Lucia Scaramella, Laura Forzenigo, Maurizio Vecchi, Monica Solbiati, Giorgio Costantino, Silvio Danese, Lorenzo D'Antiga, Sandro Sironi, Luca Elli |
| 85 |
[GO] |
2021―Aug―10 |
Gastrointestinal mucosal immunity and COVID-19 |
Tsvetelina Velikova, Violeta Snegarova, Alexander Kukov, Hristiana Batselova, Antoaneta Mihova, Radislav Nakov |
| 86 |
[GO] |
2021―Aug―03 |
Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis |
Samuel D Johnson, Omalla A Olwenyi, Namita Bhyravbhatla, Michellie Thurman, Kabita Pandey, Elizabeth A Klug, Morgan Johnston, Shetty Ravi Dyavar, Arpan Acharya, Anthony T Podany, Courtney V Fletcher, Mahesh Mohan, Kamal Singh, Siddappa N Byrareddy |
| 87 |
[GO] |
2021―Jul―26 |
Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management |
Dina Zakaria Mohamed, Mai El-Sayed Ghoneim, Sally El-Sayed Abu-Risha, Ramy Ahmed Abdelsalam, Mohamed Abdelhalem Farag |
| 88 |
[GO] |
2021―Jul―19 |
Dysregulated liver function in SARS-CoV-2 infection: Current understanding and perspectives |
Yi-Ke Huang, Yu-Jia Li, Bin Li, Pan Wang, Qing-Hua Wang |
| 89 |
[GO] |
2021―Jul―14 |
Impact of COVID-19 on the clinical status of patients with Wilson disease |
Yu-Pei Zhuang, Hao-Jie Zhong |
| 90 |
[GO] |
2021―Jul―11 |
Impact of COVID-19 on the clinical status of patients with Wilson disease |
Yu-Pei Zhuang, Hao-Jie Zhong |
| 91 |
[GO] |
2021―Jul―11 |
Inflammatory effect on the gastrointestinal system associated with COVID-19 |
Paulina Delgado-Gonzalez, Carlos A Gonzalez-Villarreal, Jorge A Roacho-Perez, Adriana G Quiroz-Reyes, Jose Francisco Islas, Juan Luis Delgado-Gallegos, Daniel Arellanos-Soto, Kame A Galan-Huerta, Elsa N Garza-Treviño |
| 92 |
[GO] |
2021―Jul―11 |
Abdominal and gastrointestinal manifestations in COVID-19 patients: Is imaging useful? |
Piero Boraschi, Luigi Giugliano, Giuseppe Mercogliano, Francescamaria Donati, Stefania Romano, Emanuele Neri |
| 93 |
[GO] |
2021―Jul―11 |
Liver dysfunction and SARS-CoV-2 infection |
Abraham Edgar Gracia-Ramos, Joel Omar Jaquez-Quintana, Raúl Contreras-Omaña, Moises Auron |
| 94 |
[GO] |
2021―Jul―05 |
Worldwide management of hepatocellular carcinoma during the COVID-19 pandemic |
Riccardo Inchingolo, Fabrizio Acquafredda, Michele Tedeschi, Letizia Laera, Gianmarco Surico, Alessia Surgo, Alba Fiorentino, Stavros Spiliopoulos, Nicola de’Angelis, Riccardo Memeo |
| 95 |
[GO] |
2021―Jul―05 |
Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence |
Marko Kumric, Tina Ticinovic Kurir, Dinko Martinovic, Piero Marin Zivkovic, Josko Bozic |
| 96 |
[GO] |
2021―Jun―25 |
COVID-19 and its effects on the digestive system |
Ting-Ting Cao, Gu-Qin Zhang, Emily Pellegrini, Qiu Zhao, Jin Li, Lin-jie Luo, Hua-Qin Pan |
| 97 |
[GO] |
2021―Jun―25 |
Neuropilin-1: A feasible link between liver pathologies and COVID-19 |
Aitor Benedicto, Iñigo García-Kamiruaga, Beatriz Arteta |
| 98 |
[GO] |
2021―Jun―17 |
Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review |
Carmelina Calitri, Ilaria Fumi, Maria Giovanna Ignaccolo, Elena Banino, Stefania Benetti, Maria Maddalena Lupica, Francesca Fantone, Mariella Pace, Franco Garofalo |
| 99 |
[GO] |
2021―Jun―17 |
COVID-19-associated diarrhea |
Klara Megyeri, Áron Dernovics, Zaid I I Al-Luhaibi, András Rosztóczy |
| 100 |
[GO] |
2021―Jun―08 |
COVID-19 and pediatric fatty liver disease: Is there interplay? |
Anna Di Sessa, Francesca Lanzaro, Sarah Zarrilli, Vittorio Picone, Stefano Guarino, Emanuele Miraglia del Giudice, Pierluigi Marzuillo |
| 101 |
[GO] |
2021―Jun―08 |
High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study |
Verena Zerbato, Stefano Di Bella, Mauro Giuffrè, Anna Wladyslawa Jaracz, Ylenia Gobbo, Diego Luppino, Paolo Macor, Ludovica Segat, Raffaella Koncan, Pierlanfranco D'Agaro, Michael Valentini, Lory Saveria Crocé, Maurizio Ruscio, Roberto Luzzati |
| 102 |
[GO] |
2021―Jun―08 |
Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury |
Dan-Dan Zhu, Xue-Mei Tan, Li-Qing Lu, Si-Jia Yu, Ru-Li Jian, Xin-Fang Liang, Yi-Xuan Liao, Wei Fan, Lucíia Barbier-Torres, Austin Yang, He-Ping Yang, Ting Liu |
| 103 |
[GO] |
2021―Jun―08 |
Liver injury in COVID-19: Detection, pathogenesis, and treatment |
Yue Cai, Li-Ping Ye, Ya-Qi Song, Xin-Li Mao, Li Wang, Yan-Zhi Jiang, Wei-Tao Que, Shao-Wei Li |
| 104 |
[GO] |
2021―Mai―26 |
Insight into molecular mechanisms underlying hepatic dysfunction in severe COVID-19 patients using systems biology |
Sarah Musa Hammoudeh, Arabella Musa Hammoudeh, Poorna Manasa Bhamidimarri, Bassam Mahboub, Rabih Halwani, Qutayba Hamid, Mohamed Rahmani, Rifat Hamoudi |
| 105 |
[GO] |
2021―Mai―20 |
COVID-19 in normal, diseased and transplanted liver |
Alessandro Signorello, Ilaria Lenci, Martina Milana, Giuseppe Grassi, Leonardo Baiocchi |
| 106 |
[GO] |
2021―Mai―13 |
Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19 |
Byungchang Jin, Rajan Singh, Se Eun Ha, Hannah Zogg, Paul J Park, Seungil Ro |
| 107 |
[GO] |
2021―Mai―13 |
Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison? |
Armando Rojas, Iván Schneider, Cristian Lindner, Ileana Gonzàlez, Miguel Angel Morales |
| 108 |
[GO] |
2021―Apr―28 |
Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment |
Cinzia Maria Chinnici, Giovanna Russelli, Matteo Bulati, Vitale Miceli, Alessia Gallo, Rosalia Busà, Rosaria Tinnirello, Pier Giulio Conaldi, Gioacchin Iannolo |
| 109 |
[GO] |
2021―Apr―21 |
Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight |
Isabela Macedo Lopes Vasques-Monteiro, Vanessa Souza-Mello |
| 110 |
[GO] |
2021―Apr―21 |
Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications |
Mohammed Al-Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy, Yasser El-Sawaf |
| 111 |
[GO] |
2021―Apr―14 |
Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges |
Fares E M Ali, Zuhair M Mohammedsaleh, Mahmoud M Ali, Osama M Ghogar |
| 112 |
[GO] |
2021―Apr―09 |
COVID-19 and the gastrointestinal tract: source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection? |
Jacopo Troisi, Giorgia Venutolo, Meritxell Pujolassos Tanyà, Matteo Delli Carri, Annamaria Landolfi, Alessio Fasano |
| 113 |
[GO] |
2021―Apr―06 |
Risk perception and knowledge of COVID-19 in patients with celiac disease |
Jamie Zhen, Juan Pablo Stefanolo, María de la Paz Temprano, Caroline L Seiler, Alberto Caminero, Enrique de-Madaria, Miguel Montoro Huguet, Vivas Santiago, Sonia Isabel Niveloni, Edgardo Gustavo Smecuol, Luis Uzcanga Dominguez, Elena Trucco, Virginia Lopez, Carolina Olano, Pasquale Mansueto, Antonio Carroccio, Peter H Green, Donald Duerksen, Andrew S Day, Jason A Tye-Din, Julio César Bai, Carolina Ciacci, Elena F Verdú, Benjamin Lebwohl, M Ines Pinto-Sanchez |
| 114 |
[GO] |
2021―Apr―06 |
Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey |
Natália Sousa Freitas Queiroz, Fábio Vieira Teixeira, Marina Pamponet Motta, Liliana Andrade Chebli, Adriano Akira Ferreira Hino, Camilla de Almeida Martins, Abel Botelho Quaresma, Alexandre Augusto de Paula da Silva, Adérson Omar Mourão Cintra Damião, Rogerio Saad-Hossne, Paulo Gustavo Kotze |
| 115 |
[GO] |
2021―Mrz―30 |
COVID-19 and comorbidities of hepatic diseases in a global perspective |
Aqsa Ahmad, Syeda Momna Ishtiaq, Junaid Ali Khan, Rizwan Aslam, Sultan Ali, Muhammad Imran Arshad |
| 116 |
[GO] |
2021―Mrz―30 |
Coronavirus disease-2019 and the intestinal tract: An overview |
Gabriela Gama Freire Alberca, Rosa Liliana Solis-Castro, Maria Edith Solis-Castro, Ricardo Wesley Alberca |
| 117 |
[GO] |
2021―Mrz―17 |
How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician |
Júlio Maria Fonseca Chebli, Natália Sousa Freitas Queiroz, Adérson Omar Mourão Cintra Damião, Liliana Andrade Chebli, Márcia Henriques de Magalhães Costa, Rogério Serafim Parra |
| 118 |
[GO] |
2021―Mrz―11 |
Impact of the COVID-19 pandemic on liver donation and transplantation: A review of the literature |
Riccardo De Carlis, Ivan Vella, Niccolò Incarbone, Leonardo Centonze, Vincenzo Buscemi, Andrea Lauterio, Luciano De Carlis |
| 119 |
[GO] |
2021―Mrz―03 |
Progressive liver injury and increased mortality risk in COVID-19 patients: A retrospective cohort study in China |
Shui-Sheng Zhang, Li Dong, Gao-Ming Wang, Yuan Tian, Xiao-Fang Ye, Yue Zhao, Zheng-Yin Liu, Jia-Yu Zhai, Zhi-Ling Zhao, Jun-Hong Wang, Hui-Min Zhang, Xiao-Long Li, Chang-Xin Wu, Cai-Ting Yang, Li-Juan Yang, Hai-Xia Du, Hui Wang, Qing-Gang Ge, Dian-Rong Xiu, Ning Shen |
| 120 |
[GO] |
2021―Mrz―03 |
Interaction between hepatitis B virus and SARS-CoV-2 infections |
Tian-Dan Xiang, Xin Zheng |
| 121 |
[GO] |
2021―Feb―20 |
Digestive system involvement of infections with SARS-CoV-2 and other coronaviruses: Clinical manifestations and potential mechanisms |
Gao-Feng Zhan, Yue Wang, Ning Yang, Ai-Lin Luo, Shi-Yong Li |
| 122 |
[GO] |
2021―Feb―05 |
Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings |
Tarun Sahu, Arundhati Mehta, Yashwant Kumar Ratre, Akriti Jaiswal, Naveen Kumar Vishvakarma, Lakkakula Venkata Kameswara Subrahmanya Bhaskar, Henu Kumar Verma |
| 123 |
[GO] |
2021―Jan―29 |
Liver injury in the era of COVID-19 |
Halina Cichoż-Lach, Agata Michalak |
| 124 |
[GO] |
2020―Dez―30 |
Lipidome is lipids regulator in gastrointestinal tract and it is a life collar in COVID-19: A review |
Khaled Mohamed Mohamed Koriem |
| 125 |
[GO] |
2020―Dez―25 |
High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data |
Luis Antonio Díaz, Francisco Idalsoaga, Macarena Cannistra, Roberto Candia, Daniel Cabrera, Francisco Barrera, Alejandro Soza, Rondell Graham, Arnoldo Riquelme, Marco Arrese, Michael D Leise, Juan Pablo Arab |
| 126 |
[GO] |
2020―Dez―14 |
Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective |
Amr Shaaban Hanafy, Sherief Abd-Elsalam |
| 127 |
[GO] |
2020―Nov―27 |
COVID-19 in a liver transplant recipient: Could iatrogenic immunosuppression have prevented severe pneumonia? A case report |
Anna Sessa, Alessandra Mazzola, Chetana Lim, Mohammed Atif, Juliana Pappatella, Valerie Pourcher, Olivier Scatton, Filomena Conti |
| 128 |
[GO] |
2020―Nov―20 |
Barriers for resuming endoscopy service in the context of COVID-19 pandemic: A multicenter survey from Egypt |
Omar Elshaarawy, Sameh Aldesoky Lashen, Nahed A Makhlouf, Doaa Abdeltawab, Mariam Salah Zaghloul, Rasha M Ahmed, Hayam Fathy, Shimaa Afifi, Muhammad Abdel-Gawad, Eman Abdelsameea, Sherief Abd-Elsalam, Salem Youssef Mohamed, Mohammed Tag-Adeen, Mina Tharwat, Ahmed Alzamzamy, Ahmed Nasr Bekhit, Alshaimaa M Eid, Abeer Awad, Mohammad Aamr, Waleed A Abd El Dayem, Mohamed-Naguib Wifi, Mohamed Alboraie |
| 129 |
[GO] |
2020―Nov―06 |
Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract |
Michail Galanopoulos, Aris Doukatas, Maria Gazouli |
| 130 |
[GO] |
2020―Okt―28 |
Insufficient etiological workup of COVID-19-associated acute pancreatitis: A systematic review |
Márk Félix Juhász, Klementina Ocskay, Szabolcs Kiss, Péter Hegyi, Andrea Párniczky |
| 131 |
[GO] |
2020―Okt―21 |
Acute gastrointestinal injury in critically ill patients with COVID-19 in Wuhan, China |
Jia-Kui Sun, Ying Liu, Lei Zou, Wen-Hao Zhang, Jing-Jing Li, Yu Wang, Xiao-Hua Kan, Jiu-Dong Chen, Qian-Kun Shi, Shou-Tao Yuan |
| 132 |
[GO] |
2020―Okt―14 |
Management of an endoscopy center during the outbreak of COVID-19: Experience from West China Hospital |
Yuan Gao, Lian-Song Ye, Jiang Du, Qiong-Ying Zhang, Bing Hu |
| 133 |
[GO] |
2020―Sep―28 |
Review of inflammatory bowel disease and COVID-19 |
Keith Sultan, Anjali Mone, Laura Durbin, Samreen Khuwaja, Arun Swaminath |
| 134 |
[GO] |
2020―Sep―27 |
Review of inflammatory bowel disease and COVID-19 |
Keith Sultan, Anjali Mone, Laura Durbin, Samreen Khuwaja, Arun Swaminath |
| 135 |
[GO] |
2020―Sep―24 |
COVID-19 pandemic and challenges in pediatric gastroenterology practice |
Jamal Kriem, Riad Rahhal |
| 136 |
[GO] |
2020―Aug―28 |
Etiology and management of liver injury in patients with COVID-19 |
Rui-Xu Yang, Rui-Dan Zheng, Jian-Gao Fan |
| 137 |
[GO] |
2020―Aug―20 |
COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract |
Michail Galanopoulos, Filippos Gkeros, Aris Doukatas, Grigorios Karianakis, Christos Pontas, Nikolaos Tsoukalas, Nikos Viazis, Christos Liatsos, Gerassimos J Mantzaris |
| 138 |
[GO] |
2020―Aug―20 |
Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan |
Hu Zhang, Yu-Sheng Liao, Jing Gong, Jing Liu, Heng Zhang |
| 139 |
[GO] |
2020―Jun―14 |
COVID-19 pandemic: Its impact on liver disease and liver transplantation |
Tevfik Tolga Sahin, Sami Akbulut, Sezai Yilmaz |
| 140 |
[GO] |
2020―Mai―20 |
Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review |
Ming Han Cha, Miguel Regueiro, Dalbir S Sandhu |
| 141 |
[GO] |
2020―Mai―20 |
Liver diseases in COVID-19: Etiology, treatment and prognosis |
Jian Wu, Shu Song, Hong-Cui Cao, Lan-Juan Li |
| 142 |
[GO] |
2020―Apr―14 |
SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant |
Kaveh Hajifathalian, Srihari Mahadev, Robert E Schwartz, Shawn Shah, Kartik Sampath, Felice Schnoll-Sussman, Robert S Brown Jr, David Carr-Locke, David E Cohen, Reem Z Sharaiha |
